Adeno-associated virus vector genomes persist as episomal chromatin in primate muscle.
about
Adeno-associated virus-mediated microRNA delivery and therapeuticsTransgene regulation using the tetracycline-inducible TetR-KRAB system after AAV-mediated gene transfer in rodents and nonhuman primatesTerminal differentiation of cardiac and skeletal myocytes induces permissivity to AAV transduction by relieving inhibition imposed by DNA damage response proteinsAdeno-associated viral vector-mediated transgene expression is independent of DNA methylation in primate liver and skeletal muscleMassively parallel cis-regulatory analysis in the mammalian central nervous systemIntegration preferences of wildtype AAV-2 for consensus rep-binding sites at numerous loci in the human genome.Role of cyclic AMP-dependent kinase response element-binding protein in recombinant adeno-associated virus-mediated transduction of heart muscle cells.A NEW RECOMBINANT ADENO-ASSOCIATED VIRUS (AAV)-BASED RANDOM PEPTIDE DISPLAY LIBRARY SYSTEM: INFECTION-DEFECTIVE AAV1.9-3 AS A NOVEL DETARGETED PLATFORM FOR VECTOR EVOLUTION.IL-2 protects lupus-prone mice from multiple end-organ damage by limiting CD4-CD8- IL-17-producing T cellsPCR-based detection of gene transfer vectors: application to gene doping surveillance.Linear amplification mediated PCR--localization of genetic elements and characterization of unknown flanking DNA.MAR-mediated integration of plasmid vectors for in vivo gene transfer and regulationGene replacement therapies for duchenne muscular dystrophy using adeno-associated viral vectors.CpG distribution and methylation pattern in porcine parvovirus.Stable human FIX expression after 0.9G intrauterine gene transfer of self-complementary adeno-associated viral vector 5 and 8 in macaquesA 10 patient case report on the impact of plasmapheresis upon neutralizing factors against adeno-associated virus (AAV) types 1, 2, 6, and 8.Cystic Fibrosis Gene Therapy in the UK and Elsewhere.Short-lived recombinant adeno-associated virus transgene expression in dystrophic muscle is associated with oxidative damage to transgene mRNA.A long-term efficacy study of gene replacement therapy for RPGR-associated retinal degenerationIntegration frequency and intermolecular recombination of rAAV vectors in non-human primate skeletal muscle and liver.Human galectin 3 binding protein interacts with recombinant adeno-associated virus type 6Bulk regional viral injection in neonatal mice enables structural and functional interrogation of defined neuronal populations throughout targeted brain areas.Infectious molecular clones of adeno-associated virus isolated directly from human tissues.Adeno-associated virus-2 and its primary cellular receptor--Cryo-EM structure of a heparin complex.Suppression of experimental uveitis by a recombinant adeno-associated virus vector encoding interleukin-1 receptor antagonistVector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeysTherapeutic expression of hairpins targeting apolipoprotein B100 induces phenotypic and transcriptome changes in murine liver.Radioiodinated Capsids Facilitate In Vivo Non-Invasive Tracking of Adeno-Associated Gene Transfer Vectors.AAV-directed muscular dystrophy gene therapy.Recombinant Adeno-Associated Virus Vector Genomes Take the Form of Long-Lived, Transcriptionally Competent Episomes in Human Muscle.Gene-based therapies of neuromuscular disorders: an update and the pivotal role of patient organizations in their discovery and implementation.Safety profile of recombinant adeno-associated viral vectors: focus on alipogene tiparvovec (Glybera®).Adeno-associated virus delivery of broadly neutralizing antibodiesMolecular basis of intervertebral disc degeneration and herniations: what are the important translational questions?Delivery of Adeno-Associated Virus Gene Therapy by Intravascular Limb Infusion Methods.Gene Targeting in Neuroendocrinology.New and improved AAVenues: current status of hemophilia B gene therapy.Systemic gene delivery transduces the enteric nervous system of guinea pigs and cynomolgus macaques.Engineering broadly neutralizing antibodies for HIV prevention and therapy.Promoter-Targeted Histone Acetylation of Chromatinized Parvoviral Genome Is Essential for the Progress of Infection.
P2860
Q27005597-F7BF6DEF-2CA3-4F26-AF9F-184FCB22DA83Q28543150-1DA8E1D8-5720-43E3-802B-3499E975D981Q28579249-196E651D-A7F2-4FC9-8343-FB41B6348728Q28743855-3227C46E-B728-4910-AF40-CDFEE2DCA169Q28973610-079E4BC0-FD37-4DD6-9BB0-F3704006BE00Q33632181-2F3E5D38-A74D-4E2B-99F9-A5D066D83ED5Q33690970-AE7F1068-63CF-4F93-8878-B535CAFB8BD8Q33908400-F085B114-B2FC-4748-982F-A897BE2CC6B5Q34053939-0B2BA526-4502-4ED9-BE91-98637583175FQ34361637-A3393677-9433-4CB5-BAFC-A3191A3CBC13Q34385265-9A2B9C9C-140F-4948-9361-EAA1CEC61897Q34447418-025BE864-30DB-4E96-95AC-A6372DB1E034Q34566454-172A65C3-A7EE-481B-8BC7-27825875A43AQ35083195-F2178BFC-EC17-404B-A226-AEB7F5FE3C0CQ35568499-39D94BBD-DD6C-4C4B-81F5-1C68FD654161Q35568505-CD7DE8C2-442B-4571-8542-B89FEEBF3255Q35641704-EA837636-F11E-4DF1-A675-E2D7A23E043CQ35651108-48DED714-BA43-4B73-9743-88A3ED17C3C0Q35766381-DADA4B7F-17B3-470E-9B3C-E43BC7B78D83Q36014088-DBE98DAA-B7BE-48C8-9E24-850339E4DD88Q36086772-BE74CBFE-DA23-48E9-BCEA-1595A906CEDAQ36249487-413DE593-C3E5-42B4-B711-613662DC697DQ37051580-6C175E10-BA5C-40AF-9F5E-CC80DE1AA1DAQ37198947-0921F855-B796-4A73-8087-01C1D33A1E0FQ37295510-DFBEA01F-2459-46E2-B83E-E7E6E3C3187AQ37295534-F0A3D00B-0E75-4394-9053-D75E0210BF96Q37434407-BDFC3B47-0DF5-468A-AF5B-87DEF7307708Q37563484-43C5BA2D-FD1C-4C34-A822-F4D3444DF649Q37687423-A1485BB8-1BD2-4524-A95B-26FE5DC7152EQ37731874-E32C8762-5539-4ACC-964A-81477EFD4C7DQ38152406-08F4E188-5CFD-43A2-BC31-95F4EA4DC06BQ38168940-7F4D5F3E-0C98-4DA4-9B25-21DBED2870EBQ38196689-F6AFAD88-DA52-4826-BCD0-87AAC129507AQ38229520-07EE221C-6836-4585-B369-2EC7B2C2A3A6Q38584256-5C0D1B6F-BED9-46DF-A4CC-C84D2E0EAE23Q38596690-6E9C784D-7A14-4AB3-B5F7-BED115C07FC9Q38622440-DCA6C8DC-0063-48A4-BFA1-54083111738BQ38644642-985DF617-8632-4DC8-94F8-934F9C2D652FQ38717198-2C69AEB2-BF26-4528-BC3F-A305DBA2D7CFQ38796863-6FC56D96-4774-4210-9DB5-52D84CA5B86F
P2860
Adeno-associated virus vector genomes persist as episomal chromatin in primate muscle.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Adeno-associated virus vector genomes persist as episomal chromatin in primate muscle.
@en
type
label
Adeno-associated virus vector genomes persist as episomal chromatin in primate muscle.
@en
prefLabel
Adeno-associated virus vector genomes persist as episomal chromatin in primate muscle.
@en
P2093
P2860
P50
P356
P1433
P1476
Adeno-associated virus vector genomes persist as episomal chromatin in primate muscle.
@en
P2093
Ali Nowrouzi
Alice Toromanoff
Caroline Le Guiner
Fabienne Rolling
Manfred Schmidt
Philippe Moullier
Pierre Chenuaud
Richard O Snyder
Yan Chérel
P2860
P304
P356
10.1128/JVI.00649-08
P407
P577
2008-06-04T00:00:00Z